Join
|
Contact
Join
|
Contact












News

Update on Cigna PC of CP Payment Policy- Feedback Requested

Blurb: 
As you will recall, in June the FSP, along with the CAP, and many other state pathology societies, successfully halted Cigna from discontinuing the reimbursement to pathologists for the professional component of clinical pathology. However, as of late, Cigna has reintroduced the policy and intends to discontinue reimbursement of the professional component. The FSP would like to hear from you regarding this policy change. Communicating and supporting our members is important to us and we appreciate your time in completing a short survey.
Publication Date: 
Tuesday, November 2, 2021 - 12:45pm

Testing for RET: A Perspective for Pathologists

Blurb: 
Amir Behdad, MD is Associate Professor of Pathology and Medicine in Hematology and Oncology and Director of Hematopathology Fellowship at the Northwestern University Feinberg School of Medicine and Director of Cancer Molecular Diagnostics at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago, Illinois. He received his medical degree from Shahid Beheshti University in Tehran, Iran before completing his internship in General Surgery at Brigham and Women’s Hospital in Boston, Massachusetts, a residency in Neurological Surgery at Washington University in St. Louis in Missouri; a residency in Anatomic and Clinical Pathology at Cedars-Sinai Medical Center in Los Angeles, California; and fellowships in Hematopathology and Molecular Genetics Pathology at the University of Michigan in Ann Arbor. Dr. Behdad also received his MBA from the Indiana University Kelley School of Business in Bloomington. He is board-certified in Anatomical and Clinical Pathology, Hematopathology, and Molecular Genetics Pathology.
Publication Date: 
Friday, October 29, 2021 - 10:30am
Tags: 
ret testing

Pages